April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
Tesla Q1: Model 2 Could Be Their Model T
Tesla Is An AI Company That The Market Won’t Reward For Now
Amazon: The Margin Train Is Gaining Speed
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Royalty Pharma (RPRX) Stock Forecast for 2024–2028. Sell or Buy?
Updated: April 25, 2024 (05:19)
Sector: HealthcareThe share price of Royalty Pharma plc (RPRX) now
50/200 Day Moving Average: $29.72 / $28.85
This figure corresponds to the Average Price over the previous 50/200 days. For Royalty Pharma stocks, the 50-day moving average is the resistance level today.
For Royalty Pharma stocks, the 200-day moving average is the resistance level today.
Are you interested in Royalty Pharma plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Royalty Pharma stock price in 2024, 2025, 2026, 2027, 2028. How much will one Royalty Pharma share be worth in 2024 - 2028?
When should I take profit in Royalty Pharma stock? When should I record a loss on Royalty Pharma stock? What are analysts' forecasts for Royalty Pharma stock? What is the future of Royalty Pharma stock? We forecast Royalty Pharma stock performance using neural networks based on historical data on Royalty Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Royalty Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Royalty Pharma shares. This happens once a day.
Historical and forecast chart of Royalty Pharma stock
The chart below shows the historical price of Royalty Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Royalty Pharma stock price can be found in the table below.
Long-term forecasts by years.
Royalty Pharma plc is a biopharmaceutical royalty purchaser and innovation sponsor for the US biopharmaceutical industry. He is also involved in identifying, evaluating and obtaining royalties for various biopharmaceuticals. In addition, the company partners with innovators from academic institutions, research hospitals and non-profit organizations, small and medium-sized biotech companies, and pharmaceutical companies.
Royalty Pharma daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Apr 27 | 28.33 | 27.61 | 28.81 | 4.37 |
| Apr 28 | 28.39 | 27.80 | 29.05 | 4.48 |
| Apr 29 | 27.75 | 27.49 | 27.93 | 1.58 |
| Apr 30 | 27.12 | 26.55 | 27.29 | 2.81 |
| May 01 | 27.20 | 26.66 | 27.53 | 3.26 |
| May 02 | 27.07 | 26.46 | 27.39 | 3.50 |
| May 03 | 27.46 | 26.97 | 27.63 | 2.44 |
| May 04 | 27.60 | 27.00 | 27.84 | 3.14 |
| May 05 | 27.00 | 26.81 | 27.61 | 3.00 |
| May 06 | 27.43 | 27.09 | 28.12 | 3.82 |
| May 07 | 27.08 | 26.83 | 27.29 | 1.71 |
| May 08 | 27.19 | 26.84 | 27.81 | 3.60 |
| May 09 | 27.52 | 26.88 | 27.78 | 3.38 |
| May 10 | 27.15 | 26.89 | 27.35 | 1.71 |
| May 11 | 26.98 | 26.48 | 27.46 | 3.72 |
| May 12 | 27.74 | 27.28 | 28.14 | 3.16 |
| May 13 | 28.55 | 28.03 | 28.95 | 3.26 |
| May 14 | 29.34 | 28.78 | 30.04 | 4.40 |
| May 15 | 29.15 | 28.67 | 29.48 | 2.83 |
| May 16 | 29.03 | 28.31 | 29.26 | 3.35 |
| May 17 | 28.74 | 28.15 | 29.36 | 4.28 |
| May 18 | 28.46 | 27.84 | 28.75 | 3.27 |
| May 19 | 28.16 | 27.54 | 28.55 | 3.66 |
| May 20 | 28.34 | 28.02 | 28.63 | 2.17 |
| May 21 | 29.20 | 28.95 | 29.52 | 1.97 |
| May 22 | 30.03 | 29.40 | 30.56 | 3.92 |
| May 23 | 29.46 | 28.82 | 29.68 | 2.98 |
| May 24 | 28.96 | 28.47 | 29.20 | 2.57 |
| May 25 | 28.18 | 27.92 | 28.91 | 3.52 |
| May 26 | 27.29 | 26.78 | 27.82 | 3.88 |
Royalty Pharma Daily Price Targets
Royalty Pharma Stock Forecast 04-27-2024.
Forecast target price for 04-27-2024: $28.33.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 4.185%.
Pessimistic target level: 27.61
Optimistic target level: 28.81
Royalty Pharma Stock Forecast 04-28-2024.
Forecast target price for 04-28-2024: $28.39.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 4.285%.
Pessimistic target level: 27.80
Optimistic target level: 29.05
Royalty Pharma Stock Forecast 04-29-2024.
Forecast target price for 04-29-2024: $27.75.
Negative dynamics for Royalty Pharma shares will prevail with possible volatility of 1.558%.
Pessimistic target level: 27.49
Optimistic target level: 27.93
Royalty Pharma Stock Forecast 04-30-2024.
Forecast target price for 04-30-2024: $27.12.
Negative dynamics for Royalty Pharma shares will prevail with possible volatility of 2.735%.
Pessimistic target level: 26.55
Optimistic target level: 27.29
Royalty Pharma Stock Forecast 05-01-2024.
Forecast target price for 05-01-2024: $27.20.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 3.162%.
Pessimistic target level: 26.66
Optimistic target level: 27.53
Royalty Pharma Stock Forecast 05-02-2024.
Forecast target price for 05-02-2024: $27.07.
Negative dynamics for Royalty Pharma shares will prevail with possible volatility of 3.384%.
Pessimistic target level: 26.46
Optimistic target level: 27.39
RPRX (RPRX) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May. | 26.96 | 26.38 | 27.34 | 3.52 |
| Jun. | 27.45 | 26.44 | 28.13 | 6.01 |
| Jul. | 26.49 | 26.05 | 27.83 | 6.40 |
| Aug. | 25.96 | 24.74 | 26.97 | 8.29 |
| Sep. | 25.43 | 24.16 | 26.50 | 8.80 |
| Oct. | 24.79 | 23.87 | 26.09 | 8.51 |
| Nov. | 24.96 | 24.10 | 25.78 | 6.51 |
| Dec. | 25.75 | 25.15 | 27.04 | 7.00 |
Royalty Pharma forecast for this year
Royalty Pharma Stock Prediction for May 2024
An downtrend is forecast for this month with an optimal target price of $26.9631. Pessimistic: $26.38. Optimistic: $27.34
Royalty Pharma Stock Prediction for Jun 2024
An uptrend is forecast for this month with an optimal target price of $27.4539. Pessimistic: $26.44. Optimistic: $28.13
Royalty Pharma Stock Prediction for Jul 2024
An downtrend is forecast for this month with an optimal target price of $26.493. Pessimistic: $26.05. Optimistic: $27.83
Royalty Pharma Stock Prediction for Aug 2024
An downtrend is forecast for this month with an optimal target price of $25.9552. Pessimistic: $24.74. Optimistic: $26.97
Royalty Pharma Stock Prediction for Sep 2024
An downtrend is forecast for this month with an optimal target price of $25.4283. Pessimistic: $24.16. Optimistic: $26.50
Royalty Pharma Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $24.7875. Pessimistic: $23.87. Optimistic: $26.09
Royalty Pharma Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $24.961. Pessimistic: $24.10. Optimistic: $25.78
Royalty Pharma Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $25.7473. Pessimistic: $25.15. Optimistic: $27.04
Royalty Pharma (RPRX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 25.95 | 24.75 | 26.71 | 7.34 |
| Feb | 25.27 | 24.51 | 26.35 | 6.98 |
| Mar | 24.07 | 23.33 | 25.37 | 8.04 |
| Apr | 23.51 | 22.71 | 24.58 | 7.63 |
| May | 25.05 | 24.57 | 26.01 | 5.53 |
| Jun | 25.97 | 25.57 | 26.67 | 4.09 |
| Jul | 26.27 | 25.49 | 27.44 | 7.10 |
| Aug | 26.52 | 25.63 | 26.95 | 4.89 |
| Sep | 26.43 | 25.38 | 27.71 | 8.41 |
| Oct | 26.97 | 26.15 | 27.40 | 4.55 |
| Nov | 28.10 | 27.53 | 29.06 | 5.28 |
| Dec | 26.92 | 25.60 | 28.28 | 9.46 |
Royalty Pharma (RPRX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 26.98 | 26.26 | 27.79 | 5.50 |
| Feb | 27.52 | 27.00 | 28.54 | 5.40 |
| Mar | 27.02 | 25.72 | 27.91 | 7.86 |
| Apr | 27.23 | 26.22 | 27.92 | 6.08 |
| May | 26.87 | 25.80 | 28.32 | 8.90 |
| Jun | 28.56 | 27.02 | 29.96 | 9.81 |
| Jul | 28.94 | 28.37 | 29.89 | 5.08 |
| Aug | 29.33 | 28.24 | 30.13 | 6.27 |
| Sep | 27.77 | 26.66 | 28.76 | 7.30 |
| Oct | 26.68 | 25.35 | 28.11 | 9.83 |
| Nov | 27.55 | 26.88 | 28.58 | 5.94 |
| Dec | 28.62 | 27.13 | 29.72 | 8.70 |
Royalty Pharma (RPRX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 27.79 | 26.51 | 29.14 | 9.01 |
| Feb | 29.47 | 27.92 | 29.88 | 6.56 |
| Mar | 30.75 | 29.41 | 31.89 | 7.76 |
| Apr | 29.80 | 29.19 | 30.84 | 5.34 |
| May | 29.65 | 28.82 | 31.21 | 7.65 |
| Jun | 31.23 | 29.61 | 31.80 | 6.87 |
| Jul | 30.27 | 28.96 | 30.90 | 6.31 |
| Aug | 29.08 | 28.57 | 30.08 | 5.01 |
| Sep | 29.00 | 28.23 | 29.87 | 5.50 |
| Oct | 28.74 | 28.05 | 30.23 | 7.19 |
| Nov | 27.91 | 27.38 | 29.08 | 5.84 |
| Dec | 29.24 | 28.34 | 29.96 | 5.40 |
Royalty Pharma (RPRX) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 30.94 | 29.58 | 32.54 | 9.12 |
| Feb | 32.22 | 31.38 | 33.57 | 6.52 |
| Mar | 31.43 | 30.39 | 33.01 | 7.93 |
| Apr | 32.51 | 31.14 | 33.62 | 7.38 |
| May | 34.33 | 32.55 | 35.96 | 9.49 |
| Jun | 35.86 | 34.41 | 37.20 | 7.49 |
| Jul | 35.19 | 33.83 | 36.96 | 8.46 |
| Aug | 33.44 | 32.41 | 35.24 | 8.04 |
| Sep | 33.27 | 32.53 | 33.76 | 3.66 |
| Oct | 33.02 | 31.42 | 34.17 | 8.05 |
| Nov | 31.93 | 31.04 | 33.36 | 6.97 |
| Dec | 31.44 | 30.01 | 32.61 | 7.96 |
Royalty Pharma information and performance
110 EAST 59TH STREET, NEW YORK, NY, US
Market capitalization of the Royalty Pharma plc is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RPRX shares in the company outstanding by the market price of one share.
EBITDA of Royalty Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Royalty Pharma (RPRX) stock dividend
Royalty Pharma last paid dividends on 05/16/2024. The next scheduled payment will be on 06/14/2024. The amount of dividends is $0.8 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
